ZYPREXA Intramuscular is a Intramuscular Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Tya Pharmaceuticals. The primary component is Olanzapine.
| Product ID | 64725-7597_5f3acc57-5fb6-4042-adf8-c2db2f41d0f8 |
| NDC | 64725-7597 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZYPREXA Intramuscular |
| Generic Name | Olanzapine |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2004-04-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021253 |
| Labeler Name | TYA Pharmaceuticals |
| Substance Name | OLANZAPINE |
| Active Ingredient Strength | 10 mg/2mL |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2012-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021253 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-06-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| OLANZAPINE | 10 mg/2mL |
| SPL SET ID: | 85688d8f-f2de-408a-8ae2-0976c266c961 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0002-7597 | ZYPREXA Intramuscular | ZYPREXA Intramuscular |
| 64725-7597 | ZYPREXA Intramuscular | ZYPREXA Intramuscular |
| 0002-4112 | Zyprexa | Olanzapine |
| 0002-4115 | Zyprexa | Olanzapine |
| 0002-4116 | Zyprexa | Olanzapine |
| 0002-4117 | Zyprexa | Olanzapine |
| 0002-4415 | Zyprexa | Olanzapine |
| 0002-4420 | Zyprexa | Olanzapine |
| 0002-4453 | ZYPREXA | Olanzapine |
| 0002-4454 | ZYPREXA | Olanzapine |
| 0002-4455 | ZYPREXA | Olanzapine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZYPREXA 75078626 2072867 Live/Registered |
Eli Lilly and Company 1996-03-26 |